The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC

por M. V. Verschueren, C. M. Cramer - van der Welle, M. Tonn, F. M. N. H. Schramel, B. J. M. Peters, E. M. W. van de Garde
Publicado 2021